Oncology

Oncology

Biology

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
21-40 of 58 ARTICLES
https://doi.org/10.12688/f1000research.127368.2
Review metrics
Revised
Exosomes: Mediators of cellular communication in potentially malignant oral lesions and head and neck cancers
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers John W Barrett; Ajaz Bhat; Jiji George
LATEST VERSION PUBLISHED 04 Oct 2023
https://doi.org/10.12688/f1000research.125272.2
Research Article metrics
Revised
Circadian disruption does not alter tumorigenesis in a mouse model of lymphoma
[version 2; peer review: 2 approved]
Peer Reviewers Chi Van Dang; Eric Zhang
  • Funder
  • National Cancer Institute
LATEST VERSION PUBLISHED 28 Sep 2023
https://doi.org/10.12688/f1000research.130316.1
Research Article metrics
Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cells
[version 1; peer review: 1 approved, 1 approved with reservations, 1 not approved]
Peer Reviewers Aamir Ahmed; Wenbin Zhou; Claudia Lanari and Andrés Elia
  • Funders
  • Al-Jalila Foundation
  • ASPIRE Precision Medicine Research Institute Abu Dhabi
PUBLISHED 08 Sep 2023
https://doi.org/10.12688/f1000research.122408.2
Research Article metrics
Revised
Methylene blue sentinel lymph node biopsy for breast cancer learning curve in the COVID-19 era: How many cases are enough?
[version 2; peer review: 2 approved]
Peer Reviewers Dedy Hermansyah; Tony Mallett and Owen Ung
LATEST VERSION PUBLISHED 29 Aug 2023
https://doi.org/10.12688/f1000research.113303.2
Research Article metrics
Revised
The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia
[version 2; peer review: 2 approved]
Peer Reviewers Fariz Nurwidya; Darren Wan-Teck Lim
LATEST VERSION PUBLISHED 15 Jun 2023
https://doi.org/10.12688/f1000research.128716.2
Review metrics
Revised
Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer
[version 2; peer review: 2 approved]
Peer Reviewers Phillip Karpowicz; Kristin Eckel-Mahan
  • Funders
  • American Cancer Society
  • National Institutes of Health
  • Johnson and Johnson
  • V Foundation for Cancer Research
LATEST VERSION PUBLISHED 16 May 2023
https://doi.org/10.12688/f1000research.122987.2
Brief Report metrics
Revised
Improving the predictive power of xenograft and syngeneic anti-tumour studies using mice humanised for pathways of drug metabolism
[version 2; peer review: 2 approved]
Peer Reviewers Russ Prough; Chris Goldring
  • Funders
  • Cancer Research UK
  • Medical Research Council
  • National Centre for the Replacement Refinement and Reduction of Animals in Research
LATEST VERSION PUBLISHED 27 Mar 2023
https://doi.org/10.12688/f1000research.129860.2
Research Article metrics
Revised
Ocimum sanctum Linn. Ethanolic extract promotes an antiproliferative and apoptosis activity in MCF-7 and T47D breast cancer cell lines mediated by upregulation of ROS/RNS, Caspase 9, and Caspase 3: an in silico and in vitro study
[version 2; peer review: 1 approved, 1 not approved]
Peer Reviewers Muhammad Lokman MD Isa; Stéphanie Grandemange
LATEST VERSION PUBLISHED 24 Mar 2023
https://doi.org/10.12688/f1000research.109136.2
Research Article metrics
Revised
Genomic profiles of Indonesian colorectal cancer patients
[version 2; peer review: 2 approved]
Peer Reviewers Ahmad Rusdan Handoyo Utomo; Wei Zhang
  • Funder
  • Indonesian Ministry of Research, Technology, and Higher Education through the World Class Research (WCR) 2019 Program
LATEST VERSION PUBLISHED 21 Feb 2023
https://doi.org/10.12688/f1000research.129490.1
Research Article metrics
Toblerone: detecting exon deletion events in cancer using RNA-seq
[version 1; peer review: 2 approved]
Peer Reviewers Katherine Pillman; Matt Field
  • Funder
  • National Health and Medical Research Council
PUBLISHED 03 Feb 2023
https://doi.org/10.12688/f1000research.129089.1
Opinion Article metrics
Genetic evolution and cellular interactions within the tumour microenvironment determine glioblastoma progression
[version 1; peer review: 1 approved]
Peer Reviewers Dinorah Friedmann-Morvinski
  • Funders
  • Mark Hughes Foundation
  • James N Kirby Foundation
  • BF Foundation
  • Cure Brain Cancer Foundation
  • Charlie Teo Foundation
  • National Health and Medical Research Council
  • Neurosurgical Research Foundation
  • BrainStorm Brain Cancer Research
PUBLISHED 13 Jan 2023
https://doi.org/10.12688/f1000research.110903.2
Software Tool Article metrics
Revised
SL-Cloud: A Cloud-based resource to support synthetic lethal interaction discovery
[version 2; peer review: 2 approved]
Peer Reviewers Jane Usher; Nishanth Ulhas Nair
  • Funder
  • National Cancer Institute
LATEST VERSION PUBLISHED 22 Dec 2022
https://doi.org/10.12688/f1000research.129084.1
Research Article metrics AWAITING PEER REVIEW
Three-dimensional wavelet decomposition-based radiomics analysis for tumor characterization in patients with oropharyngeal squamous cell carcinoma
[version 1; peer review: awaiting peer review]
Peer Reviewers Invited
  • Funder
  • Varian Medical Systems
PUBLISHED 21 Dec 2022
https://doi.org/10.12688/f1000research.108628.2
Review metrics
Revised
p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
[version 2; peer review: 2 approved]
Peer Reviewers Didik Setyo Heriyanto; Norbert Nass
LATEST VERSION PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.109551.2
Brief Report metrics
Revised
Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease
[version 2; peer review: 2 approved]
Peer Reviewers Antonio Bedalov; Makoto Sasaki
  • Funders
  • Japanese Society of Hematology
  • Ministry of Education, Culture, Sports, Science and Technology
LATEST VERSION PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.127427.1
Case Report metrics
Case Report: Spontaneous remission of early T-cell precursor acute lymphoblastic leukemia
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Rosana Pelayo
PUBLISHED 30 Nov 2022
https://doi.org/10.12688/f1000research.126337.1
Review metrics
Role of RAS signaling in ovarian cancer
[version 1; peer review: 2 approved]
Peer Reviewers Shams Tabrez; Haider Raza and Annie John
  • Funder
  • Medical Research center, Hamad Medical Corporation
PUBLISHED 04 Nov 2022
https://doi.org/10.12688/f1000research.122434.2
Case Report metrics
Revised
Case Report: Focal leptomeningeal disease, atypical cancer of unknown primary site
[version 2; peer review: 2 approved]
Peer Reviewers Miguel Oswaldo Cadena-Sanabria; José Percy Amado Tineo
LATEST VERSION PUBLISHED 21 Sep 2022
https://doi.org/10.12688/f1000research.123884.1
Study Protocol metrics
The burden of BRCA1 and BRCA2 gene mutations among Vietnamese women and their associated factors: A protocol for a systematic review and meta-analysis
[version 1; peer review: 1 not approved]
Peer Reviewers Weang Kee Ho and Boon Hong Ang
PUBLISHED 28 Jul 2022
https://doi.org/10.12688/f1000research.110268.2
Research Article metrics
Revised
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain
[version 2; peer review: 2 approved]
Peer Reviewers Manushak Avagyan; Durga Neupane
  • Funder
  • Sociedad Española de Oncología Médica
LATEST VERSION PUBLISHED 26 Jul 2022
21-40 of 58 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.